Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Authors
Keywords
Mild Cognitive Impairment, Down Syndrome, Cerebral Amyloid Angiopathy, White Matter Hyperintensities, Mild Cognitive Impairment Subject
Journal
Alzheimers Research & Therapy
Volume 5, Issue 2, Pages 8
Publisher
Springer Nature
Online
2013-03-08
DOI
10.1186/alzrt162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
- (2012) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- (2012) Michal J. Figurski et al. Alzheimers & Dementia
- β-Amyloid Dynamics in Human Plasma
- (2012) Yafei Huang et al. ARCHIVES OF NEUROLOGY
- Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers
- (2012) Gary Tong et al. CLINICAL THERAPEUTICS
- Stability of amyloid-β peptides in plasma and serum
- (2012) Mirko Bibl et al. ELECTROPHORESIS
- Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2
- (2012) Carla A. Ibrahim-Verbaas et al. HUMAN GENETICS
- Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer Disease
- (2012) Nilay S. Shah et al. HYPERTENSION
- Interplay between α-, β-, and γ-Secretases Determines Biphasic Amyloid-β Protein Level in the Presence of a γ-Secretase Inhibitor
- (2012) Fernando Ortega et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease
- (2012) Robert A. Rissman et al. JOURNAL OF NEURAL TRANSMISSION
- Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
- (2012) David A Wolk et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
- (2012) Eric M Reiman et al. LANCET NEUROLOGY
- Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
- (2011) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
- (2011) Stephen D. Weigand et al. Alzheimers & Dementia
- Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2011) Hugo Vanderstichele et al. Alzheimers & Dementia
- Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of the Amyloid β Monoclonal Antibody Solanezumab in Japanese and White Patients With Mild to Moderate Alzheimer Disease
- (2011) Kazunori Uenaka et al. CLINICAL NEUROPHARMACOLOGY
- Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
- (2011) Bruno P Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline
- (2011) Kristine Yaffe JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of Florbetapir-PET for Imaging β-Amyloid Pathology
- (2011) Christopher M. Clark JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- γ-Secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment
- (2011) Ting Li et al. JOURNAL OF NEUROCHEMISTRY
- Plasma β amyloid and the risk of Alzheimer's disease in Down syndrome
- (2011) Antonia M.W. Coppus et al. NEUROBIOLOGY OF AGING
- Plasma A and PET PiB binding are inversely related in mild cognitive impairment
- (2011) D. P. Devanand et al. NEUROLOGY
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- The Relationship of Plasma Aβ Levels to Dementia in Aging Individuals With Down Syndrome
- (2010) Yasuji Matsuoka et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease
- (2010) Imrich Blasko et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Plasma β-Amyloid and Cognitive Decline
- (2010) Stephanie A. Cosentino et al. ARCHIVES OF NEUROLOGY
- Change in plasma A peptides and onset of dementia in adults with Down syndrome
- (2010) N. Schupf et al. NEUROLOGY
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- Ten-Year Change in Plasma Amyloid β Levels and Late-Life Cognitive Decline
- (2009) Olivia I. Okereke et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid tau and ptau181increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
- (2009) Anne M. Fagan et al. EMBO Molecular Medicine
- Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
- (2009) P. Lewczuk et al. EXPERIMENTAL NEUROLOGY
- Plasmaβ-amyloid and duration of Alzheimer's disease in adults with Down syndrome
- (2009) V. P. Prasher et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- No correlation between time-linked plasma and CSF Aβ levels
- (2009) Nathalie Le Bastard et al. NEUROCHEMISTRY INTERNATIONAL
- Association of plasma amyloid with risk of dementia: The prospective Three-City Study
- (2009) J. -C. Lambert et al. NEUROLOGY
- Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
- (2008) Alex E. Roher et al. Alzheimers & Dementia
- Plasma Amyloid β-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease
- (2008) Joseph J. Locascio et al. ARCHIVES OF NEUROLOGY
- Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men
- (2008) Johan Sundelöf et al. ARCHIVES OF NEUROLOGY
- Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
- (2008) Oskar Hansson et al. NEUROBIOLOGY OF AGING
- Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
- (2008) O. L. Lopez et al. NEUROLOGY
- Peripheral A subspecies as risk biomarkers of Alzheimer's disease
- (2008) N. Schupf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma amyloid protein is elevated in late-onset Alzheimer disease families
- (2007) N. Ertekin-Taner et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now